Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives FDA’s Approval Of BELVIX XR CIV.

The approval of a weight-loss drug from Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) by the FDA was a plus for the company’s shares. The approval of the New Drug Application (NDA) for BELVIX XR CIV extended release 20 mg tablets is another milestone for the company as expressed by Arena’s CEO Amit Munshi, which shows its commitment to […]

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging

Boston, MA 04/07/2014 (wallstreetpr) – For pharmaceutical companies, coming up with a good drug is one thing and making the most out of the drug is another. In fact, in most cases, great drugs fail to turn anticipated value mostly due to poor marketing strategies. That being the case, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) seems to have […]